



In their letter, Drobeniuc and
Spaulding question the selected analytic
approach to our randomized controlled
trial of a comprehensive intervention to
maintain plasma HIV RNA suppression
after prison release. Specifically, issue is
taken with the use of an intent-to-treat
analysis comparing the rates of virologic
suppression at 24 weeks after prison
release between the 2 study arms.
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cess after prison release. The absence of
a significant difference between the
study arms in the primary and almost
all secondary outcomes suggests to us
that there are strong societal forces that
our intervention did not address. That
a substantial proportion of HIV-infected
people in the United States, particularly
those living in deep poverty, can only
achieve and maintain desirable health
outcomes while incarcerated implicates
these forces as the main target for
change, rather than the behaviors of
those they affect.
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Although investigators use a variety of 
approaches to address missing outcome 
data in intent-to-treat analyses, including 
complete case analyses and simple 
imputation methods, we recognized that 
in this trial of men and women re-
entering their communities after incar-
ceration, missing data due to lost to 
follow-up and re-incarceration would 
not be trivial. To address this, the 
primary analysis used multiple imputa-
tion to estimate missing outcomes 
based on 10 major characteristics mea-
sured at baseline.1,2 Therefore, all par-
ticipants contributed data to the primary 
endpoint of this study, regardless of 
whether or not the participant 
was reincarcerated.
The multiple imputation modeling, 
in our view, is preferable to the actual 
measurement of viral load of those 
reincarcerated for a number of reasons. 
Foremost, the overarching aim of our trial 
was to test an intervention to maintain 
viral suppression in the community after 
incarceration to reduce the risk of sec-
ondary transmission of the virus. Those 
who are reincarcerated are no longer in 
these communities, and therefore, the 
determination of the efficacy of the 
intervention to reduce secondary trans-
mission is no longer possible. Our model 
estimates the rates of viral suppression 
had these men and women remained in 
their communities. In addition, the study 
intervention was designed to encourage 
and support community HIV care and 
treatment adherence, and not viral sup-
pression while in a correctional facility. 
The systems in place to administer and 
support HIV therapy in prisons and jails 
are starkly different from those found in 
the community.
Importantly, there is no reason to 
believe that the inclusion of viral load 
data from the participants who were 
reincarcerated would have altered the 
main findings of our trial. That the study 
intervention would have led to better or 
worse odds of viral suppression during 
reincarceration is highly unlikely, and 
other interventions should be developed 
and tested to improve HIV outcomes 
during incarceration.
We do agree with Drobeniuc and 
Spaulding that there are consequences of 
mass incarceration, especially among 
HIV-infected persons, that impede suc-
